Table 3.
Detection rate and potential yield of stepwise CMD risk assessment
| High-risk category | NNS | |
|---|---|---|
| GP visit | ||
| N = 1755 | N = 30 934 | |
| Newly diagnosed: % (n) | ||
| Hypertensiona | 9.2 (n = 161) | |
| Hypercholesterolemiab | 9.6 (n = 169) | |
| Diabetes mellitusc | 1.6 (n = 28) | |
| Newly prescribed without recorded diagnosis: % (n) | ||
| Antihypertensivesd | 1.3 (n = 23) | |
| Lipid-lowering drugse | 1.4 (n = 25) | |
| Antidiabeticsf | 0 (n = 0) | |
| Abnormal diagnostic test without recorded diagnosis or prescription: % (n) | ||
| Blood pressure ≥140/90 mmHg | 18.1 (n = 318) | |
| Total cholesterol/HDL ratio ≥5–8 | 8.0 (n = 140) | |
| Total cholesterol ≥8 mmol/l or total cholesterol/HDL ratio ≥8 | 0.4 (n = 7) | |
| Fasting glucose ≥6–7 mmol/l (prediabetes) | 21.9 (n = 385) | |
| Fasting glucose ≥7 mmol/l | 0.3 (n = 5) | |
| Newly diagnosed CMD, newly prescribed or abnormal diagnostic test result % (n) | ||
| No. of participants with newly diagnosed CMDg | 19.7 (n = 346) | 89 |
| No. of participants with newly diagnosed CMD or prescriptionh | 21.9 (n = 385) | 80 |
| No. of participants with new CMD, prescription or abnormal diagnostic test | 43.8 (n = 768) | 40 |
aICPC codes: K86/K87.
bICPC code: T93.
cICPC code: T90.
dATC cluster: C02–03, C07–C09.
eATC cluster: C10.
fATC cluster: A10.
gICPC codes: K74, K75, K76, K77, K86, K87, K89, K90, K91, K92, T90 and T93.
hICPC codes + ATC cluster: A10 and C02–03, C07–C10.
CMD, cardiometabolic disease; GP, general practitioner; NNS, number needed to screen; ICPC, International Classification of Primary Care; ATC, Anatomical Therapeutic Chemical Classification System.